FDA Antidepressant Data Was Fully Disclosed, Agency Tells Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
Although there was internal disagreement on the implications of pediatric antidepressant data, all information was reviewed publicly, the agency maintains in a letter to the House Energy & Commerce/Oversight Subcommittee.